Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Mar 13.
Published in final edited form as: ACS Nano. 2016 Sep 16;10(9):8732–8737. doi: 10.1021/acsnano.6b04207

Fully Zwitterionic Nanoparticle Antimicrobial Agents through Tuning of Core Size and Ligand Structure

Shuaidong Huo †,‡,¶,§, Ying Jiang †,§, Akash Gupta , Ziwen Jiang , Ryan Landis , Singyuk Hou , Xing-Jie Liang ‡,¶,*, Vincent M Rotello †,*
PMCID: PMC5848071  NIHMSID: NIHMS947940  PMID: 27622756

Abstract

Zwitterionic nanoparticles are generally considered non-toxic and non-interacting. Here, we report effective and selective antimicrobial activity of zwitterionic gold nanoparticles (AuNP) through modulation NP size and surface charge orientation. Using a set of 2, 4 and 6 nm core AuNPs, increasing particle size increased antimicrobial efficiency through bacterial membrane disruption. Further improvement was observed through control of ligand structure, generating antimicrobial particles with low hemolytic activity and demonstrating the importance of size and surface structure in dictating the bioactivity properties of nanomaterials.

Keywords: antimicrobial activity, size, charge orientation, zwitterionic gold nanoparticles

Graphical Abstract

graphic file with name nihms947940u1.jpg


Pathogenic bacteria are a serious threat to public health, with acquired antibiotic resistance challenging the effectiveness of traditional antimicrobials.1,2 Nanoparticles (NPs) have attributes that make them promising antimicrobial agents.37 For example, the high surface area to volume ratio of NPs enables the efficient encapsulation/conjugation of antibiotics.810 Cationic nanoparticles provide self-therapeutic antimicrobial systems that function through bacterial membrane penetration and disruption.1114 These positively charged NPs, however, can possess substantial toxicity to mammalian cells, including hemolytic activity.15,16 Integrating neutral zwitterionic ligands into cationic nanoparticles has created a class of NP-based antimicrobial that decrease mammalian cells toxicity and maintain antifouling properties.17,18 Activity in these systems, however, requires careful balancing of zwitterionic and cationic ligands to ensure the stability and antibacterial activity of the nanoparticles.11,19,20

In addition to surface functionalization, there is mounting evidence indicating that size and monolayer structure of NPs also plays a significant role in determining the bactericidal activity of NPs.21,22 For example, we have previously found that cationic gold nanoparticles (AuNP) displayed very different interaction patterns with bacterial membrane between 2 nm and 6 nm core sizes.23

Here, we report the design and synthesis of family of fully zwitterionic NP-based antimicrobials. The antibacterial activity of these zwitterionic NPs was readily manipulated by tuning the NP core size. Small-NPs (2 nm core) display low antimicrobial activity. Surprisingly, modestly larger 6 nm core AuNPs exhibit very potent antimicrobial activity, efficiently disrupting the bacterial cell membrane. In addition, subtle tuning of the surface charge orientations of zwitterionic AuNPs results in a substantial change of antimicrobial activity. Noteworthy, all these zwitterionic nanoparticles exhibit low toxicity to mammalian cells and maintain high hemocompatibility. The parametric engineering of NPs provides both different bactericidal therapeutics and insight into the coupled role of size and surface functionality on the antimicrobial activity.

RESULTS AND DISCUSSION

Zwitterionic surface are known to inhibit bacterial adhesion and prevent biofilm formation, 18,24 however their bactericidal ability has not been well explored. In this study, two sets of zwitterionic ligands were designed to synthesize zwitterionic monolayer-protected gold nanoparticles. These zwitterionic ligands display different charge orientations (Figure 1A), one has positive charges in the outermost layer (SN), while the other one has the positive charge inside the ligand terminus (NS).

Figure 1.

Figure 1

(A) Chemical structure of zwitterionic ligands used for AuNP synthesis. Zwitterionic headgroups were conjugated to a non-interacting oligo(ethylene glycol)-functionalized interior. (B) TEM images and the corresponding size distribution histograms of zwitterionic AuNPs with 2, 4, and 6 nm core size. (C) The minimum inhibitory concentration (MIC) of zwitterionic Au-SN and Au-NS NPs against Gram-negative (P. aeruginosa) and Gram-positive (A. azurea) bacterial strains. Bacteria were cultured overnight with NPs and the experiments repeated in triplicate.

Three sets of zwitterionic AuNPs with different core size were synthesized by reducing chloroauric acid in the presence of precisely controlled ratio of SN or NS ligand as described in Supporting Information.2528 With the molar ratio of gold salt to surface ligand increased from 1/3 to 3/1, AuNPs with core size of 2, 4, and 6 nm were obtained (Figure 1B). Dynamic light scattering (DLS) analysis (Table S1) confirms the increased NP size under the different reaction molar ratio. Additionally, zeta-potential measurements showed nearly neutral charges of both Au-NS and Au-SN NPs. The successful surface functionalization of nanoparticles with zwitterionic ligands was also analyzed and verified using laser desorption/ionization mass spectrometry (LDI-MS, Figure S1). Molecular peaks observed at m/z value of 530.2 and 601.1 were attributed to NS and SN ligands, respectively.

We first evaluated the antimicrobial activities of these zwitterionic AuNPs against Gram-positive and Gram-negative bacterial strains. Two antibiotic resistant pathogenic strains were tested: P. aeruginosa (Pseudomonas aeruginosa, Gram-negative) and A. azurea (Amycolatopsis azurea, Gram-positive).29,30 The minimal inhibitory concentration (MIC) of each NP against these bacteria was determined using broth dilution method in the presence of nanoparticles of varying concentrations.31 As shown in Figure 1C, all zwitterionic NPs were able to completely inhibit the proliferation of P. aeruginosa and A. azurea. There was a significant effect of particle size on bacteria proliferation. As an example, the MIC concentration of Au-SN NP against Gram-negative P. aeruginosa decreased from 8000 nM to 50 nM when the core size of NP was increased from 2 nm to 6 nm. A similar trend was observed for the Gram-positive A. azurea strain (Table S2), with the 6 nm NP displaying a 40-fold lower MIC than the 2 nm analog. Surface structure likewise played a role in bactericidal efficacy: all of the Au-SN NPs were more effective than these Au-NS analogs. Our finding is consistent with the previous study where cationic-terminated particles were more toxic to both Gram-negative and Gram-positive bacterial strains than anion-terminated particles.11 Collectively, our study demonstrated that both the size and charge orientation of zwitterionic NPs are crucial in determining the antimicrobial properties of these zwitterionic AuNPs.

Having demonstrated the distinct size- and charge orientation-dependent antimicrobial activity of zwitterionic AuNPs, we set out to understand the antibacterial mechanism of these NPs. To this end, we treated P. aeruginosa and A. azurea with NPs at their respective MIC concentrations for 3 hours (Table S2), followed by examining the bacterial morphology and NP-bacterial membrane interaction using transmission electron microscopy (TEM). As shown in Figure 2, both Gram-negative and -positive strains without NPs treatment exhibit typical membrane structures, with thin or thick peptidoglycans readily identified.32 The morphology and membrane integrity of the bacteria, however, were dramatically changed after NPs treatment in a size-dependent fashion. Smaller 2 nm NPs were randomly adsorbed on bacteria and on the TEM substrate without inducing noticeable membrane changes. However, 4 and 6 nm NPs penetrated deeper into the peptidoglycan layer and anchored more strongly on the bacterial surface, with 6 nm NP attaching the most. Noteworthy, with more NP accumulation on the bacterial surface a higher degree of membrane damage was observed. Moreover, some outer membrane vesicles (OMVs) began to form on the cell membrane after incubation with 4 nm Au-SN NP as denoted in Figure 2. This blebbing can be attributed to the NP aggregation formation on the bacterial surface as indicated by red arrows (Figure 2). Significantly, we observed a higher efficiency of these NPs to disrupt Gram-negative P. aeruginosa. The multilayered peptidoglycan coating of Gram-positive bacteria presumably passivates the interactions of NPs and bacterial membranes, leading to less NPs penetration and decreased toxicity of NPs against gram-positive bacteria. Au-NS NP displayed a similar interaction trend with P. aeruginosa and A. azurea, but with decreased bacteria disruption efficiency compared to that of Au-SN NP. More SN nanoparticles were found sticking onto the cell surface than NS, with greater structural damage observed (Figure 2,) indicating the positive charge terminated SN ligands have higher affinity to the negatively changed bacterial membrane then the NS analogs. As expected, this effect is magnified for larger particle that feature increased surface contact areas. These observations correlate well with the MIC studies where Au-SN NP shows superior antimicrobial activities compared to that of Au-NS NP (Table S2 and Figure S2).

Figure 2.

Figure 2

Visualizing morphological changes in cell membranes using TEM. (A) Gram-negative (P. aeruginosa) and (B) Gram-positive (A. azurea) bacterial strains were treated with 2, 4 and 6 nm Au-SN and Au-NS NPs at their MIC concentration for 3 h. Red arrows indicate the morphological changes of cell membrane structures with and without NPs treatment. Scale bars: 200 nm for black and 500 nm for white.

Having observed NPs-induced bacterial membrane distortions, we surmised that membrane damage induced by NPs provided their antimicrobial activities. To verify this hypothesis, we treated bacteria with the most potent 6 nm NPs, followed by propidium iodide (PI) staining to check the integrity of bacteria membrane. PI only leaks into cells with compromised membranes, with concomitant enhanced fluorescence.6,8 As shown in Figure 3, Figure S3 and Figure S4, we only observed strong red fluoresce from bacterial cells treated with NPs, indicating the integrity of bacterial membrane was indeed disrupted by NPs.

Figure 3.

Figure 3

Propidium iodide staining assays of Gram-negative (P. aeruginosa) bacterial strain after 3 h incubation with 6 nm zwitterionic NPs at each MIC concentration via confocal microscopy observation.

The above studies demonstrate that the larger AuNPs are efficient bactericidal agents. Effective applications of antimicrobials in or on patients, however, require a low toxicity to mammalian cells, and in particular red blood cells (RBCs).5,33 To this end, we first studied the toxicity of zwitterionic NPs against fibroblast 3T3 cells that have been widely used to determine the cytotoxicity and biocompatibility of antibacterial agents.34 As shown in Figure S5, the treatment of 3T3 cells with AuNPs at individual MIC concentration had negligible cytotoxicity as measured by Alamar Blue assay. The hemolytic activity of these NPs against human red blood cells (RBCs) was also measured.15,35,36 As shown in Figure 4, Figure S6 and Figure S7, at the concentrations we tested (up to 16-fold higher than the MIC concentration, with highest dosing determined by the high optical density of the AuNPs), none of the NPs show any observable hemolytic activity, demonstrating the intrinsic biocompatibility of zwitterionic ligands with mammalian cells and human blood cells.

Figure 4.

Figure 4

Hemolysis assay study of sub-10 nm zwitterionic gold nanoparticles at several concentrations on human red blood cells for 30 min at 37 °C. The mixture was centrifuged to detect the cell-free hemoglobin in the supernatant. RBCs incubated with PBS as well as water were used as negative (−) and positive (+) control, respectively. All samples were prepared in triplicate at one time. MIC of Each NP was indicated using the red arrows above the wells.

The observed effect of NP size is substantial compared with the relatively small increase in particle diameter. The most reasonable explanation for the greater antimicrobial activity of the larger particles is the increase in monolayer pre-organization that occurs with increasing particle core diameter. Murray’s study of nanoparticle monolayers indicates that as the size of NPs increases, the surface curvature decreases, leading to a more densely packed ligand shell.37 Small diameter (2 nm core) NPs feature disorganized ligand shells, whereas larger NPs (> 4.4 nm) feature highly organized “2D-like” surfaces. The greater pre-organization of the larger particles presumably presents more terminal charged groups toward cell surface, causing membrane distortion, and eventually lysis the cell (Figure 5). Furthermore, the higher surface area of larger particles would be expected to increase the interaction energy of these particles with membranes.

Figure 5.

Figure 5

Schematic illustration of interaction mechanism between bacterial membrane with 2 nm and 6 nm core sized zwitterionic nanoparticles.

CONCLUSIONS

In summary, we have demonstrated an important synergy between NP core size, surface charge orientations, and antimicrobial behavior of zwitterionic gold nanoparticles. We observed a dramatically increased antimicrobial property with increasing NP size, with changes of charge orientation also substantially contributing to antimicrobial activity. Significantly, all NPs maintained their intrinsic biocompatibility toward mammalian and in particular red blood cells, making these systems promising for antimicrobial therapeutic use. In a broader context, this study provides direct demonstration that subtle changes in NP size and surface functionality can dramatically alter the interactions of these materials with biosystems, showing the importance of these attributes in predicting NP behavior.

METHODS

Determination of antimicrobial activities (MIC) of zwitterionic gold nanoparticles

The minimum inhibitory concentration (MIC) is defined as the lowest concentration of AuNP that inhibits visible growth after overnight incubation as observed with the naked eyes.38 First, bacteria were cultured in LB medium at 37 °C and 275 rpm until into stationary phase. The cultured bacteria were then harvested by centrifugation and washed with 0.85% sodium chloride solution for at least three times. Optical density measurement at 600 nm was used to determine the concentration of re-suspended bacterial solution. Then, 50 μL of bacteria solution was mixed with another 50 μL NP solutions in a 96-well plate, reaching a final bacterial concentration of 5 × 105 cfu/mL. NPs concentration cultured with bacteria varied in half fold according to the standard protocol.31 A growth control group treated without NPs and a sterile control group with only growth medium M9 were carried out at the same time. All of the cultures were performed in triplicates, and at least two independent experiments were repeated on different days.

TEM observation of cell membrane structure

For TEM grid preparation, 20 μL of the bacteria solution (OD600 nm = 0.35) was mixed with nanoparticle solution (10 μL, 2000 nM for 2 nm, 900 nM for 4 nm, 500 nM for 6 nm) at room temperature. After incubation for 3 h, aliquots of the mixture were applied to a carbon-coated Cu grid (400-mesh). Aliquots of 2 μL were allowed to settle on the grid for 30 s and then blotted with filter paper slightly. In order to distinguish the cell membranes, the grids were stained with 2 μL of 1% uranyl acetate for 30 s and then blotted again. All grids were then screened with FEI TecaniT12 microscope with an accelerating voltage of 120 kV.

Propidium iodide staining assay study

First, P. aeruginosa (Gram-negative) and A. azurea (Gram-positive) (1×108 cfu/mL) were incubated with 6 nm nanoparticles at each MIC concentration in M9 buffer at 37 °C and 275 rpm for 3 h. Then, bacteria solutions were mixed with 2 μM PI and incubated for 30 min in dark. After that, 10 μL of the samples was placed on a glass slide with a coverslip and observed under a confocal laser scanning microscopy using a 543 nm excitation wavelength (Zeiss 510, Carl Zeiss, Germany).

Hemolysis assay

Hemolysis assay was performed on human red blood cells (RBCs).39 In this work, citrate stabilized human whole blood (pooled, mixed gender) was purchased from Bioreclamation LLC, Westbury, NY. First, the RBCs were centrifuged for five times and resuspended in 10 mL of PBS buffer as soon as received. Then, 0.1 mL of RBC solution mixed with 0.4 mL of NP solution in PBS. After incubation at 37 °C, 150 rpm for 30 min, the mixture was centrifuged at 4000 rpm for 5 min. At last, the absorbance value of the supernatant was measured at 570 nm. RBCs incubated with PBS and water was used as negative and positive control, respectively. All samples were prepared in triplicate at one time. The percent hemolysis was calculated using the following equation: %Hemolysis = (sample absorbance - negative control absorbance)/(positive control absorbance - negative control absorbance) × 100.

Supplementary Material

ESI

Acknowledgments

This work was supported by the grants from the NIH (GM077173), the National Natural Science Foundation key project (31430031), the National Distinguished Young Scholars grant (31225009) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA09030301) and financial support from China Scholarship Council.

Footnotes

Conflicts of Interest: The authors declare no competing financial interests.

Supporting Information Available: Nanoparticle synthesis and characterization, and additional experimental details and figures. This material is available free of charge via the Internet at http://pubs.acs.org.

References

  • 1.Gerner-Smidt P, Kincaid J, Kubota K, Hise K, Hunter SB, Fair MA, Norton D, Woo-Ming A, Kurzynski T, Sotir MJ, Head M, Holt K, Swaminathan B. Molecular Surveillance of Shiga Toxigenic Escherichia coli O157 by PulseNet USA. J Food Prot. 2005;68:1926–1931. doi: 10.4315/0362-028x-68.9.1926. [DOI] [PubMed] [Google Scholar]
  • 2.Lushniak BD. Antibiotic Resistance: A Public Health Crisis. Public Health Rep. 2014;129:314–316. doi: 10.1177/003335491412900402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.De M, Ghosh PS, Rotello VM. Applications of Nanoparticles in Biology. Adv Mater. 2008;20:4225–4241. [Google Scholar]
  • 4.Miller KP, Wang L, Benicewicz BC, Decho AW. Inorganic Nanoparticles Engineered to Attack Bacteria. Chem Soc Rev. 2015;44:7787–7807. doi: 10.1039/c5cs00041f. [DOI] [PubMed] [Google Scholar]
  • 5.Richter AP, Brown JS, Bharti B, Wang A, Gangwal S, Houck K, Cohen Hubal EA, Paunov VN, Stoyanov SD, Velev OD. An Environmentally Benign Antimicrobial Nanoparticle Based on a Silver-Infused Lignin Core. Nat Nanotechnol. 2015;10:817–823. doi: 10.1038/nnano.2015.141. [DOI] [PubMed] [Google Scholar]
  • 6.Li X, Robinson SM, Gupta A, Saha K, Jiang Z, Moyano DF, Sahar A, Riley MA, Rotello VM. Functional Gold Nanoparticles as Potent Antimicrobial Agents Against Multi-Drug-Resistant Bacteria. ACS Nano. 2014;8:10682–10686. doi: 10.1021/nn5042625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Zhao YY, Ye CJ, Liu WW, Chen R, Jiang XY. Tuning the Composition of AuPt Bimetallic Nanoparticles for Antibacterial Application. Angew Chem Int Ed. 2014;53:8127–8131. doi: 10.1002/anie.201401035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Zhao Y, Tian Y, Cui Y, Liu W, Ma W, Jiang X. Small Molecule-Capped Gold Nanoparticles as Potent Antibacterial Agents that Target Gram-Negative Bacteria. J Am Chem Soc. 2010;132:12349–12356. doi: 10.1021/ja1028843. [DOI] [PubMed] [Google Scholar]
  • 9.Grace AN, Pandian K. Antibacterial Efficacy of Aminoglycosidic Antibiotics Protected Gold Nanoparticles-A Brief Study. Colloid Surf A. 2007;297:63–70. [Google Scholar]
  • 10.Gu H, Ho P, Tong E, Wang L, Xu B. Presenting Vancomycin on Nanoparticles to Enhance Antimicrobial Activities. Nano Lett. 2003;3:1261–1263. [Google Scholar]
  • 11.Feng ZV, Gunsolus IL, Qiu TA, Hurley KR, Nyberg LH, Frew H, Johnson KP, Vartanian AM, Jacob LM, Lohse SE. Impacts of Gold Nanoparticle Charge and Ligand Type on Surface Binding and Toxicity to Gram-Negative and Gram-Positive Bacteria. Chem Sci. 2015;6:5186–5196. doi: 10.1039/c5sc00792e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Carmona-Ribeiro AM, de Melo Carrasco LD. Cationic Antimicrobial Polymers and Their Assemblies. Int J Mol Sci. 2013;14:9906–9946. doi: 10.3390/ijms14059906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Fang B, Jiang Y, Rotello VM, Nusslein K, Santore MM. Easy Come Easy Go: Surfaces Containing Immobilized Nanoparticles or Isolated Polycation Chains Facilitate Removal of Captured Staphylococcus Aureus by Retarding Bacterial Bond Maturation. ACS Nano. 2014;8:1180–1190. doi: 10.1021/nn405845y. [DOI] [PubMed] [Google Scholar]
  • 14.Fang B, Jiang Y, Nusslein K, Rotello VM, Santore MM. Antimicrobial Surfaces Containing Cationic Nanoparticles: How Immobilized, Clustered, and Protruding Cationic Charge Presentation Affects Killing Activity and Kinetics. Colloid Surf B. 2015;125:255–263. doi: 10.1016/j.colsurfb.2014.10.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Goodman CM, McCusker CD, Yilmaz T, Rotello VM. Toxicity of Gold Nanoparticles Functionalized with Cationic and Anionic Side Chains. Bioconjugate Chem. 2004;15:897–900. doi: 10.1021/bc049951i. [DOI] [PubMed] [Google Scholar]
  • 16.Zhang Z, Zhang M, Chen S, Horbett TA, Ratner BD, Jiang S. Blood Compatibility of Surfaces with Superlow Protein Adsorption. Biomaterials. 2008;29:4285–4291. doi: 10.1016/j.biomaterials.2008.07.039. [DOI] [PubMed] [Google Scholar]
  • 17.Jiang S, Cao Z. Ultralow-Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications. Adv Mater. 2010;22:920–932. doi: 10.1002/adma.200901407. [DOI] [PubMed] [Google Scholar]
  • 18.Cheng G, Zhang Z, Chen SF, Bryers JD, Jiang SY. Inhibition of Bacterial Adhesion and Biofilm Formation on Zwitterionic Surfaces. Biomaterials. 2007;28:4192–4199. doi: 10.1016/j.biomaterials.2007.05.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Bresee J, Maier KE, Boncella AE, Melander C, Feldheim DL. Growth Inhibition of Staphylococcus Aureus by Mixed Monolayer Gold Nanoparticles. Small. 2011;7:2027–2031. doi: 10.1002/smll.201100420. [DOI] [PubMed] [Google Scholar]
  • 20.Adhikari MD, Goswami S, Panda BR, Chattopadhyay A, Ramesh A. Membrane-Directed High Bactericidal Activity of (Gold Nanoparticle) Polythiophene Composite for Niche Applications Against Pathogenic Bacteria. Adv Healthcare Mater. 2013;2:599–606. doi: 10.1002/adhm.201200278. [DOI] [PubMed] [Google Scholar]
  • 21.Yamamoto O. Influence of Particle Size on the Antibacterial Activity of Zinc Oxide. Int J Inorg Mater. 2001;3:643–646. [Google Scholar]
  • 22.Raghupathi KR, Koodali RT, Manna AC. Size-Dependent Bacterial Growth Inhibition and Mechanism of Antibacterial Activity of Zinc Oxide Nanoparticles. Langmuir. 2011;27:4020–4028. doi: 10.1021/la104825u. [DOI] [PubMed] [Google Scholar]
  • 23.Hayden SC, Zhao GX, Saha K, Phillips RL, Li XN, Miranda OR, Rotello VM, El-Sayed MA, Schmidt-Krey I, Bunz UHF. Aggregation and Interaction of Cationic Nanoparticles on Bacterial Surfaces. J Am Chem Soc. 2012;134:6920–6923. doi: 10.1021/ja301167y. [DOI] [PubMed] [Google Scholar]
  • 24.Mi L, Jiang SY. Integrated Antimicrobial and Nonfouling Zwitterionic Polymers. Angew Chem Int Ed. 2014;53:1746–1754. doi: 10.1002/anie.201304060. [DOI] [PubMed] [Google Scholar]
  • 25.Huo SD, Jin SB, Ma XW, Xue XD, Yang KN, Kumar A, Wang PC, Zhang JC, Hu ZB, Liang XJ. Ultrasmall Gold Nanoparticles as Carriers for Nucleus-Based Gene Therapy Due to Size-Dependent Nuclear Entry. ACS Nano. 2014;8:5852–5862. doi: 10.1021/nn5008572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Huang KY, Ma HL, Liu J, Huo SD, Kumar A, Wei T, Zhang X, Jin SB, Gan YL, Wang PC, He ST, Zhang XN, Liang XJ. Size-Dependent Localization and Penetration of Ultrasmall Gold Nanoparticles in Cancer Cells, Multicellular Spheroids, and Tumors in Vivo. ACS Nano. 2012;6:4483–4493. doi: 10.1021/nn301282m. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Jiang Y, Huo SD, Mizuhara T, Das R, Lee YW, Hou S, Moyano DF, Duncan B, Liang XJ, Rotello VM. The Interplay of Size and Surface Functionality on the Cellular Uptake of Sub-10 nm Gold Nanoparticles. ACS Nano. 2015;9:9986–9993. doi: 10.1021/acsnano.5b03521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mizuhara T, Saha K, Moyano DF, Kim CS, Yan B, Kim YK, Rotello VM. Acylsulfonamide-Functionalized Zwitterionic Gold Nanoparticles for Enhanced Cellular Uptake at Tumor pH. Angew Chem Int Ed. 2015;54:6567–6570. doi: 10.1002/anie.201411615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Nikaido H. Multidrug Efflux Pumps of Gram-Negative Bacteria. J Bacteriol. 1996;178:5853–5859. doi: 10.1128/jb.178.20.5853-5859.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Phillips RL, Miranda OR, You CC, Rotello VM, Bunz UHF. Rapid and Efficient Identification of Bacteria Using Gold-Nanoparticle-Poly(para-phenyleneethynylene) Constructs. Angew Chem Int Ed. 2008;47:2590–2594. doi: 10.1002/anie.200703369. [DOI] [PubMed] [Google Scholar]
  • 31.Wiegand I, Hilpert K, Hancock REW. Agar and Broth Dilution Methods to Determine the Minimal Inhibitory Concentration (MIC) of Antimicrobial Substances. Nat Protoc. 2008;3:163–175. doi: 10.1038/nprot.2007.521. [DOI] [PubMed] [Google Scholar]
  • 32.Cabeen MT, Jacobs-Wagner C. Bacterial Cell Shape. Nat Rev Microbiol. 2005;3:601–610. doi: 10.1038/nrmicro1205. [DOI] [PubMed] [Google Scholar]
  • 33.Rizzello L, Cingolani R, Pompa PP. Nanotechnology Tools for Antibacterial Materials. Nanomedicine-UK. 2013;8:807–821. doi: 10.2217/nnm.13.63. [DOI] [PubMed] [Google Scholar]
  • 34.Duncan B, Li X, Landis RF, Kim CS, Gupta A, Wang LS, Ramanathan R, Tang R, Boerth JA, Rotello VM. Nanoparticle-Stabilized Capsules for the Treatment of Bacterial Biofilms. ACS Nano. 2015;9:7775–7782. doi: 10.1021/acsnano.5b01696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Dobrovoiskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE. Method for Analysis of Nanoparticle Hemolytic Properties in Vitro. Nano Lett. 2008;8:2180–2187. doi: 10.1021/nl0805615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lin YS, Haynes CL. Impacts of Mesoporous Silica Nanoparticle Size, Pore Ordering, and Pore Integrity on Hemolytic Activity. J Am Chem Soc. 2010;132:4834–4842. doi: 10.1021/ja910846q. [DOI] [PubMed] [Google Scholar]
  • 37.Hostetler MJ, Wingate JE, Zhong CJ, Harris JE, Vachet RW, Clark MR, Londono JD, Green SJ, Stokes JJ, Wignall GD, Glish GL, Porter MD, Evans ND, Murray RW. Alkanethiolate Gold Cluster Molecules with Core Diameters from 1.5 to 5. 2 nm: Core and Monolayer Properties as a Function of Core Size. Langmuir. 1998;14:17–30. [Google Scholar]
  • 38.Andrews JM. Determination of Minimum Inhibitory Concentrations. J Antimicrob Chemother. 2001;48:5–16. doi: 10.1093/jac/48.suppl_1.5. [DOI] [PubMed] [Google Scholar]
  • 39.Saha K, Moyano DF, Rotello VM. Protein Coronas Suppress the Hemolytic Activity of Hydrophilic and Hydrophobic Nanoparticles. Mater Horiz. 2014;1:102–105. doi: 10.1039/C3MH00075C. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ESI

RESOURCES